Femme Vital

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

Dioscorea oppositifolia, Quantity: 40 mg (Equivalent: Dioscorea oppositifolia, Qty 200 mg); Bupleurum falcatum, Quantity: 20 mg (Equivalent: Bupleurum falcatum, Qty 200 mg); calcium amino acid chelate, Quantity: 50 mg (Equivalent: calcium, Qty 10 mg); Angelica polymorpha, Quantity: 50 mg (Equivalent: Angelica polymorpha, Qty 200 mg); magnesium amino acid chelate, Quantity: 50 mg (Equivalent: magnesium, Qty 10 mg); Vitex agnus-castus, Quantity: 10 mg (Equivalent: Vitex agnus-castus, Qty 100 mg); calcium hydrogen phosphate dihydrate, Quantity: 350.36 mg (Equivalent: calcium, Qty 81.6 mg); Rehmannia glutinosa, Quantity: 200 mg (Equivalent: Rehmannia glutinosa, Qty 1.2 g); Paeonia lactiflora, Quantity: 28.57 mg (Equivalent: Paeonia lactiflora, Qty 200 mg); colecalciferol, Quantity: 0.0025 mg

Available from:

Vitex Pharmaceuticals Pty Ltd

Pharmaceutical form:

Tablet, film coated

Composition:

Excipient Ingredients: microcrystalline cellulose; Carnauba Wax; colloidal anhydrous silica; magnesium stearate; croscarmellose sodium; titanium dioxide; hypromellose; iron oxide yellow; iron oxide red; macrogol 4000; maize starch; silicon dioxide; dl-alpha-tocopherol; sucrose; hydrolysed gelatin; hydrogenated soya oil

Administration route:

Oral

Therapeutic indications:

Maintain/support general health and wellbeing ; Traditionally used in Chinese medicine to Decrease/reduce/relieve symptoms of menopause

Product summary:

Visual Identification: ;

Authorization status:

Listed

Authorization date:

2019-06-28